Pfizer to Buy Antibiotics From AstraZeneca for $725 Million

  • U.K. drugmaker to get up to $850 million if certain goals met
  • Deal gives Pfizer Zavicefta for drug-resistant infections

Pfizer Inc. agreed to buy an antibiotics business from AstraZeneca Plc for $725 million as well as other payouts, settling for one piece of a company it once tried to acquire.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.